Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-10 |
mRNA | STXBP5L | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
mRNA | SYP | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-10 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
mRNA | HECTD4 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
mRNA | ZNF439 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |